This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

M. J. Friedrich

JAMA. 1999;281:973-975.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Houston—Identification of the cellular and genetic abnormalities involved in all types of cancer is providing new therapeutic avenues for researchers to pursue. Efforts to translate this knowledge into innovative therapies for ovarian cancer took the spotlight at the first International Conference on Ovarian Cancer, held at the University of Texas last month.

Ovarian cancer, which has the highest mortality rate of all gynecologic cancers and is the fourth leading cause of cancer deaths among women in the United States, can usually be treated and cured if caught early. But all too often, it causes only vague symptoms that go unnoticed until the tumor is advanced and the prognosis is poor.

A scanning electron micrograph of cancer cells in the human ovary shows the variety of shapes and sizes typical of their chaotic arrangement and growth. (Photo credit: Photo Researchers Inc)

To discuss the latest advances in . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?